RAP 0.00% 20.5¢ resapp health limited

Ann: ResApp Extends SMARTCOUGH-C Study, page-2

  1. 1,424 Posts.
    lightbulb Created with Sketch. 855
    Here we go ladies and gents.

    6 weeks to go at the latest, incorporating a wider array of respiratory diseases. New target 1500 patients to gain enough statistically significant pneumonia and croup patients.

    Still on track for results and submission by the first half of this year.
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.